Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm
- PMID: 26698666
- DOI: 10.1016/j.freeradbiomed.2015.12.012
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm
Abstract
Clinical studies suggest a link between peripheral insulin resistance and cognitive dysfunction. Interestingly, post-mortem analyses of Alzheimer disease (AD) subjects demonstrated insulin resistance in the brain proposing a role for cognitive deficits observed in AD. However, the mechanisms responsible for the onset of brain insulin resistance (BIR) need further elucidations. Biliverdin reductase-A (BVR-A) emerged as a unique Ser/Thr/Tyr kinase directly involved in the insulin signaling and represents an up-stream regulator of the insulin signaling cascade. Because we previously demonstrated the oxidative stress (OS)-induced impairment of BVR-A in human AD brain, we hypothesize that BVR-A dysregulation could be associated with the onset of BIR in AD. In the present work, we longitudinally analyze the age-dependent changes of (i) BVR-A protein levels and activation, (ii) total oxidative stress markers levels (PC, HNE, 3-NT) as well as (iii) IR/IRS1 levels and activation in the hippocampus of the triple transgenic model of AD (3xTg-AD) mice. Furthermore, ad hoc experiments have been performed in SH-SY5Y neuroblastoma cells to clarify the molecular mechanism(s) underlying changes observed in mice. Our results show that OS-induced impairment of BVR-A kinase activity is an early event, which starts prior the accumulation of Aβ and tau pathology or the elevation of TNF-α, and that greatly contribute to the onset of BIR along the progression of AD pathology in 3xTg-Ad mice. Based on these evidence we, therefore, propose a new paradigm for which: OS-induced impairment of BVR-A is firstly responsible for a sustained activation of IRS1, which then causes the stimulation of negative feedback mechanisms (i.e. mTOR) aimed to turn-off IRS1 hyper-activity and thus BIR. Similar alterations characterize also the normal aging process in mice, positing BVR-A impairment as a possible bridge in the transition from normal aging to AD.
Keywords: 3xTg-AD mice; Alzheimer disease; Biliverdin reductase-A; Insulin resistance; Oxidative stress.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: Implications for Alzheimer disease.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3181-3194. doi: 10.1016/j.bbadis.2018.07.005. Epub 2018 Jul 5. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29981845
-
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.Neurobiol Dis. 2019 May;125:176-189. doi: 10.1016/j.nbd.2019.02.003. Epub 2019 Feb 6. Neurobiol Dis. 2019. PMID: 30738142
-
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease.Mol Neurobiol. 2019 Apr;56(4):2922-2943. doi: 10.1007/s12035-018-1231-5. Epub 2018 Aug 2. Mol Neurobiol. 2019. PMID: 30073505
-
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.Neurobiol Dis. 2014 Feb;62:144-59. doi: 10.1016/j.nbd.2013.09.018. Epub 2013 Oct 2. Neurobiol Dis. 2014. PMID: 24095978 Free PMC article. Review.
-
Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings.Curr Drug Targets. 2010 Dec;11(12):1586-94. doi: 10.2174/1389450111009011586. Curr Drug Targets. 2010. PMID: 20704544 Review.
Cited by
-
Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites.Biomedicines. 2022 Jul 2;10(7):1582. doi: 10.3390/biomedicines10071582. Biomedicines. 2022. PMID: 35884888 Free PMC article. Review.
-
Biliverdin reductase-A attenuated GMH-induced inflammatory response in the spleen by inhibiting toll-like receptor-4 through eNOS/NO pathway.J Neuroinflammation. 2018 Apr 20;15(1):118. doi: 10.1186/s12974-018-1155-z. J Neuroinflammation. 2018. PMID: 29678206 Free PMC article.
-
The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative Diseases.Antioxidants (Basel). 2020 Sep 22;9(9):900. doi: 10.3390/antiox9090900. Antioxidants (Basel). 2020. PMID: 32971784 Free PMC article. Review.
-
Diagnosis of Amnesic Mild Cognitive Impairment Using MGS-WBC and VGBN-LM Algorithms.Front Aging Neurosci. 2022 May 30;14:893250. doi: 10.3389/fnagi.2022.893250. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35707699 Free PMC article.
-
GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review.Curr Top Med Chem. 2024;24(19):1635-1664. doi: 10.2174/0115680266293416240515075450. Curr Top Med Chem. 2024. PMID: 38803170 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous